Perfil
Scott Moorefield served as the Senior Vice President of Business Development at Silverback Therapeutics, Inc. and as the Chief Business Officer at Boundless Bio, Inc. from 2019 to 2020.
He holds a doctorate degree from North Carolina State University, which he received in 2005, and an undergraduate degree from The University of North Carolina at Chapel Hill, which he received in 1996.
Antiguos cargos conocidos de Scott Moorefield.
| Empresas | Cargo | Fin |
|---|---|---|
| ARS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/03/2022 |
| BOUNDLESS BIO, INC. | Corporate Officer/Principal | 01/06/2020 |
Formación de Scott Moorefield.
| The University of North Carolina at Chapel Hill | Undergraduate Degree |
| North Carolina State University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| BOUNDLESS BIO, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Silverback Therapeutics, Inc.
 Silverback Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Silverback Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the proprietary ImmunoTAC technology platform to develop systemically delivered, tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases. The company was founded by Peter A. Thompson January 4, 2016 and is headquartered in Seattle, WA. | Health Technology |
- Bolsa de valores
- Insiders
- Scott Moorefield